Innovative therapies for ovarian cancer, including engineered T cells and antibody-drug conjugates, show promise in improving ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.

Pro-inflammatory signaling molecules in MS cause problems with the growth and development of myelin-making cells in the brain ...

To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

including whether immune cells such as T cells have become activated to kill tumors, or whether tumor cells are susceptible to a specific drug. “These predictions are all based on looking at ...

Here, Dr. Fishman sifts through some of the myths regarding the disease. The discomfort of ovarian cancer is real, not vague. It’s more that you can mistake symptoms for other things.

Mother with ovarian cancer underwent surgery that had medics remove her womb with her baby and hold it outside her body while ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer ... head and neck squamous cell carcinoma. That trial marked the ...